These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21693303)

  • 1. Dry eye disease in chronic graft-versus-host disease: results from a Spanish retrospective cohort study.
    de la Parra-Colín P; Agahan AL; Pérez-Simón JA; López A; Caballero D; Hernández E; Barrientos-Gutierrez T; Calonge M
    Transplant Proc; 2011 Jun; 43(5):1934-8. PubMed ID: 21693303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Corneal complications after hematopoietic stem cell transplantation].
    Mittelviefhaus H; Auw-Hädrich C
    Ophthalmologe; 2003 Mar; 100(3):222-9. PubMed ID: 12640552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular graft-versus-host disease after allogeneic stem cell transplantation.
    Westeneng AC; Hettinga Y; Lokhorst H; Verdonck L; van Dorp S; Rothova A
    Cornea; 2010 Jul; 29(7):758-63. PubMed ID: 20489577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous lacrimal punctal occlusion associated with ocular chronic graft-versus-host disease.
    Kamoi M; Ogawa Y; Dogru M; Uchino M; Kawashima M; Goto E; Mori T; Okamoto S; Shimazaki J; Tsubota K
    Curr Eye Res; 2007 Oct; 32(10):837-42. PubMed ID: 17963103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q; Dong M; Wang QM; Wen JY; Wu XY
    Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Ogawa Y; Okamoto S; Mori T; Yamada M; Mashima Y; Watanabe R; Kuwana M; Tsubota K; Ikeda Y; Oguchi Y
    Bone Marrow Transplant; 2003 Apr; 31(7):579-83. PubMed ID: 12692625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical cyclosporine-A in dry eye associated with chronic graft versus host disease.
    Kurt RA; Yalçindag N; Atilla H; Arat M
    Ann Ophthalmol (Skokie); 2009; 41(3-4):166-9. PubMed ID: 20214049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
    Labbé AC; Su SH; Laverdière M; Pépin J; Patiño C; Cohen S; Kiss T; Lachance S; Sauvageau G; Busque L; Roy DC; Roy J
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the kinetics of CD3+ chimerism and the incidence of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Rupa-Matysek J; Lewandowski K; Nowak W; Sawiński K; Gil L; Komarnicki M
    Transplant Proc; 2011 Jun; 43(5):1915-23. PubMed ID: 21693300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome.
    Skert C; Patriarca F; Sperotto A; Cerno M; Filì C; Zaja F; Stocchi R; Geromin A; Damiani D; Fanin R
    Haematologica; 2006 Feb; 91(2):258-61. PubMed ID: 16461315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior uveitis: a manifestation of graft-versus-host disease.
    Hettinga YM; Verdonck LF; Fijnheer R; Rijkers GT; Rothova A
    Ophthalmology; 2007 Apr; 114(4):794-7. PubMed ID: 17187864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD.
    Ogawa Y; Yamazaki K; Kuwana M; Mashima Y; Nakamura Y; Ishida S; Toda I; Oguchi Y; Tsubota K; Okamoto S; Kawakami Y
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):111-9. PubMed ID: 11133855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry-eye syndrome after allogeneic stem-cell transplantation in children.
    Fahnehjelm KT; Törnquist AL; Winiarski J
    Acta Ophthalmol; 2008 May; 86(3):253-8. PubMed ID: 18093259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Chiang CC; Lin JM; Chen WL; Tsai YY
    Cornea; 2007 Aug; 26(7):861-3. PubMed ID: 17667623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD.
    Ogawa Y; Dogru M; Uchino M; Tatematsu Y; Kamoi M; Yamamoto Y; Ogawa J; Ishida R; Kaido M; Hara S; Matsumoto Y; Kawakita T; Okamoto S; Tsubota K
    Bone Marrow Transplant; 2010 Mar; 45(3):565-9. PubMed ID: 19633693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
    Cutler C; Li S; Kim HT; Laglenne P; Szeto KC; Hoffmeister L; Harrison MJ; Ho V; Alyea E; Lee SJ; Soiffer R; Sonis S; Antin JH
    Biol Blood Marrow Transplant; 2005 May; 11(5):383-8. PubMed ID: 15846292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease.
    Colombo AA; Rusconi C; Esposito C; Bernasconi P; Caldera D; Lazzarino M; Alessandrino EP
    Transplantation; 2006 Apr; 81(8):1087-92. PubMed ID: 16641591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.